JP2000041689A - Production of inositol - Google Patents

Production of inositol

Info

Publication number
JP2000041689A
JP2000041689A JP13341899A JP13341899A JP2000041689A JP 2000041689 A JP2000041689 A JP 2000041689A JP 13341899 A JP13341899 A JP 13341899A JP 13341899 A JP13341899 A JP 13341899A JP 2000041689 A JP2000041689 A JP 2000041689A
Authority
JP
Japan
Prior art keywords
inositol
producing
microorganism
halogenated
pyruvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13341899A
Other languages
Japanese (ja)
Inventor
Reiko Miyata
令子 宮田
Koji Igarashi
浩司 五十嵐
Toru Yonehara
徹 米原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP13341899A priority Critical patent/JP2000041689A/en
Publication of JP2000041689A publication Critical patent/JP2000041689A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain inositol important as a kind of vitamin useful for a nutritive food, a feed additive, a medicine, etc., in a high yield by using a fungus having resistance to a halogenated pyruvic acid, capable of secreting and producing inositol. SOLUTION: A fungus [e.g. Candida boidinii BP22 (FERM P-15,743), etc.], having resistance to a halogenated pyruvic acid, capable of secreting and producing inositol is cultured in a medium, inositol is accumulated in a culture solution and collected from the culture solution to give the objective inositol important as a kind of vitamin in higher animals useful for a nutritive food, a feed additive, a medicine, etc., in a high yield economically. Candida boidinii BP22 strain is obtained by treating Candida boidinii δ-65 (FERM P-15, 743) (FERM P-15,379) with a mutagenetic agent and culturing the treated strain under conditions in which no parent strain can grow.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】イノシトールは、高等動物に
おいてビタミンの一種として重要な物質で、栄養食品、
飼料添加物、医薬品などに利用される。
BACKGROUND OF THE INVENTION Inositol is an important substance as a type of vitamin in higher animals,
Used for feed additives and pharmaceuticals.

【0002】[0002]

【従来の技術】従来イノシトールは、米糠、コーンステ
ィープリカーなどからの抽出(特開昭61−56142
号公報)、パン酵母を培養して製造する方法(欧州特許
公開第506289)などが知られている。また、本発
明者らによるキャンディダ属に属する微生物を培養して
製造する方法(特開平8−258号公報、特開平8−8
9266号公報、特開平8−38188号公報)があ
る。
2. Description of the Related Art Conventionally, inositol has been extracted from rice bran, corn steep liquor and the like (JP-A-61-56142).
And a method of culturing and producing baker's yeast (European Patent Publication No. 506289). Further, a method of culturing and producing a microorganism belonging to the genus Candida by the present inventors (JP-A-8-258, JP-A-8-8)
9266, JP-A-8-38188).

【0003】[0003]

【発明が解決しようとする課題】米糠、コーンスティー
プリカーなどから抽出する方法は、イノシトール以外の
不純物が多く、精製が困難であり、経済的に問題があ
る。また、パン酵母を培養して製造する方法は、生産性
が低く、やはり経済的に問題があり、さらに工業的実績
もない。また、キャンディダ属に属する微生物を培養し
て製造する方法は、工業的に収率、収量の点で満足いく
ものではなかった。
The method of extracting rice bran, corn steep liquor and the like contains many impurities other than inositol, is difficult to purify, and is economically problematic. In addition, the method of culturing and producing baker's yeast has low productivity, is still economically problematic, and has no industrial record. In addition, the method of culturing and producing a microorganism belonging to the genus Candida has not been industrially satisfactory in terms of yield and yield.

【0004】[0004]

【課題を解決するための手段】本発明者らは、上記問題
点を解決するため、キャンディダ属に属する微生物の変
異株がイノシトールを収率、収量良く蓄積する事を見い
出した。本発明者らはさらに生産性の高いイノシトール
の製造方法について鋭意研究した結果、イノシトールの
生産能を有する微生物に、ハロゲン化ピルビン酸に対す
る耐性を付与することにより、イノシトールの蓄積濃
度、生成収率が著しく向上することを見出し本発明に到
達した。
Means for Solving the Problems In order to solve the above problems, the present inventors have found that a mutant strain of a microorganism belonging to the genus Candida accumulates inositol in good yield and yield. The present inventors have conducted intensive studies on a method for producing inositol with higher productivity, and as a result, by imparting resistance to halogenated pyruvate to a microorganism capable of producing inositol, the accumulated concentration of inositol and the production yield were reduced. The present inventors have found that the temperature is remarkably improved, and arrived at the present invention.

【0005】すなわち、本発明はハロゲン化ピルビン酸
に耐性を有し、かつイノシトールを分泌する性質を持っ
た微生物を培養して、培養液中にイノシトールを蓄積せ
しめ、前記培養液よりイノシトールを採取することおよ
び、ハロゲン化ピルビン酸耐性を有し、かつイノシトー
ル生産能を有する微生物を培養して、得られた菌体、も
しくはそれらの処理物を用い、イノシトールを生成蓄積
せしめる反応を行い、前記反応液よりイノシトールを採
取することを特徴とするイノシトールの製造方法であ
る。
That is, the present invention comprises culturing a microorganism which is resistant to halogenated pyruvate and has the property of secreting inositol, accumulates inositol in the culture solution, and collects inositol from the culture solution. And culturing a microorganism having tolerance to pyruvate halide and capable of producing inositol, and performing a reaction to produce and accumulate inositol using the obtained cells or a processed product thereof, and the reaction solution A method for producing inositol, which comprises collecting more inositol.

【0006】ここでいうハロゲン化ピルビン酸とは、ピ
ルビン酸代謝拮抗物質である。すなわち、微生物の生育
を阻害する物質を添加し、ピルビン酸の生合成系あるい
は分解に関与する酵素の抑制あるいは阻害作用を示し、
その抑制あるいは阻害がピルビン酸の添加により回復す
る物質である。ハロゲン化ピルビン酸としては、ブロモ
ピルビン酸、フルオロピルビン酸、クロロピルビン酸な
どが挙げられ、各々の物質を単独、または組み合わせて
用いることができる。
[0006] The halogenated pyruvic acid as used herein is a pyruvate antimetabolite. That is, by adding a substance that inhibits the growth of microorganisms, it exhibits an inhibitory or inhibitory effect on enzymes involved in pyruvate biosynthesis or decomposition,
It is a substance whose inhibition or inhibition is restored by the addition of pyruvic acid. Examples of the halogenated pyruvic acid include bromopyruvic acid, fluoropyruvic acid, chloropyruvic acid, and the like, and the respective substances can be used alone or in combination.

【0007】[0007]

【発明の実施の形態】本発明に使用する微生物は、イノ
シトールを分泌する微生物であるならばいずれでもよい
が、親株としては、本発明者らによりヘキサクロロシク
ロヘキサン耐性変異株として取得された、キャンディダ
・ボイディニイ(Candida boidinii)
δ−65(FERM P−15739)を用いることが
好ましい。イノシトールを分泌する性質があれば、他
に、薬剤に対する耐性、栄養要求性などの性質があって
もよく、イノシトールを分泌する微生物はすべて本発明
に含まれるものである。
BEST MODE FOR CARRYING OUT THE INVENTION The microorganism used in the present invention may be any microorganism that secretes inositol, and the parent strain is Candida, a hexachlorocyclohexane-resistant mutant obtained by the present inventors.・ Voidinii (Candida boidinii)
It is preferable to use δ-65 (FERM P-15739). As long as it has the property of secreting inositol, it may also have properties such as resistance to drugs and auxotrophy, and any microorganism that secretes inositol is included in the present invention.

【0008】変異株の誘導は親株を紫外線照射するか、
あるいは変異誘発剤(たとえばN−メチル−N′−ニト
ロ−N−ニトロソグアニジン、エチルメタンスルホン酸
など)で処理した後、親株が生育できないような濃度の
ハロゲン化ピルビン酸を含む固体培地で生育可能な菌株
を採取すればよい。
[0008] The induction of the mutant strain may be carried out by irradiating the parent strain with ultraviolet light,
Alternatively, after treatment with a mutagenic agent (for example, N-methyl-N'-nitro-N-nitrosoguanidine, ethyl methanesulfonic acid, etc.), growth is possible on a solid medium containing pyruvate halide at such a concentration that the parent strain cannot grow. What is necessary is just to collect various strains.

【0009】ハロゲン化ピルビン酸耐性変異株は、親株
よりハロゲン化ピルビン酸に強い耐性を有する株のこと
である。本発明においては、親株の相対生育度の30%
以下を示すハロゲン化ピルビン酸の濃度範囲において6
0%以上の相対生育度を示す変異株を取得するのが好ま
しい。ここでの相対生育度は培養液の660nmにおけ
る吸光度を測定し、ハロゲン化ピルビン酸を添加してい
ない培養液の吸光度を100%とした時の相対値で示
す。耐性を検定する場合のハロゲン化ピルビン酸は市販
のものを用いればよい。
[0009] A halogenated pyruvate-resistant mutant is a strain that is more resistant to halogenated pyruvate than the parent strain. In the present invention, the relative growth rate of the parent strain is 30%.
In the concentration range of halogenated pyruvic acid which shows:
It is preferable to obtain a mutant showing a relative growth degree of 0% or more. Here, the relative growth was measured by measuring the absorbance of the culture at 660 nm, and expressed as a relative value when the absorbance of the culture without the addition of halogenated pyruvic acid was taken as 100%. Commercially available halogenated pyruvic acid may be used for assaying the resistance.

【0010】本発明における培養方法について説明す
る。イノシトール生産用の培地は、炭素源、窒素源、無
機イオンおよび必要に応じてその他の有機微量成分を含
有する通常の培地である。
The culturing method of the present invention will be described. The medium for producing inositol is an ordinary medium containing a carbon source, a nitrogen source, inorganic ions and, if necessary, other organic trace components.

【0011】炭素源としては、グルコース、フラクトー
ス、でんぷんおよびセルロースの加水分解物、糖蜜など
の糖類、フマール酸、クエン酸、コハク酸のごとき有機
酸、メタノール、エタノール、グリセロールのごときア
ルコール類などを1〜15%、窒素源として、酢酸アン
モニウムのごとき有機アンモニウム塩、硫酸アンモニウ
ム、塩化アンモニウム、リン酸アンモニウム、硝酸アン
モニウム、のごとき無機アンモニウム塩、アンモニアガ
ス、アンモニア水、尿素等を0.1〜4.0%、有機微
量成分としては、ビオチン等の被要求性物質が0.00
0001%〜0.1%、また必要に応じて、コーンステ
ィープリカー、ペプトン、酵母エキス等0〜5%をそれ
ぞれ適当に含有する培地が用いられる。これらの他に、
リン酸カリウム、硫酸マグネシウム、塩化カルシウム、
塩化ナトリウム、硫酸亜鉛、硫酸銅、硫酸第1鉄、等が
微量成分として添加される。また好ましくは消泡剤など
も添加し、培養条件の安定化をはかる。
Examples of the carbon source include glucose, fructose, hydrolysates of starch and cellulose, sugars such as molasses, organic acids such as fumaric acid, citric acid and succinic acid, and alcohols such as methanol, ethanol and glycerol. 0.1 to 4.0% of an organic ammonium salt such as ammonium acetate, an inorganic ammonium salt such as ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium nitrate, ammonia gas, aqueous ammonia, urea, etc. as a nitrogen source. As the organic trace component, the required substance such as biotin is 0.00%.
A medium containing 0001% to 0.1%, and if necessary, 0 to 5% of corn steep liquor, peptone, yeast extract and the like, respectively, is appropriately used. In addition to these,
Potassium phosphate, magnesium sulfate, calcium chloride,
Sodium chloride, zinc sulfate, copper sulfate, ferrous sulfate, etc. are added as trace components. Preferably, an antifoaming agent is also added to stabilize the culture conditions.

【0012】培養は通常、好気条件で行う。培養の間、
培地のpH3〜8に、温度は20〜35℃に調節し、2
4〜96時間振とうまたは通気撹拌培養すれば好ましい
結果が得られる。
The culture is usually performed under aerobic conditions. During the culture,
The pH of the medium is adjusted to 3-8, the temperature is adjusted to 20-35 ° C,
Preferable results can be obtained by shaking or aeration and stirring culture for 4 to 96 hours.

【0013】次に本発明における酵素法でのイノシトー
ルの生産方法について説明する。前記発酵法における培
地と同様に培養し、菌体をえる。この菌体をそのまま反
応に用いてもよいが、好ましくは、公知の方法で原形質
分離化処理して行う。反応原料は、ニコチンアミドアデ
ニンジヌクレオチド、アンモニア存在下で行い、pHは
3〜8、温度は20〜35℃で10〜72時間振盪して
行う。
Next, a method for producing inositol by the enzymatic method according to the present invention will be described. The cells are cultured in the same manner as in the medium in the fermentation method to obtain cells. This cell may be used for the reaction as it is, but preferably, it is subjected to a protoplasmic separation treatment by a known method. The reaction is carried out in the presence of nicotinamide adenine dinucleotide and ammonia at a pH of 3 to 8 and a temperature of 20 to 35 ° C. with shaking for 10 to 72 hours.

【0014】培養液中に分泌蓄積されたイノシトール
は、そのまま単離採取することなく、飼料などに用いる
ことができる。また、培養液あるいは反応液からイノシ
トールを採取するには公知の方法で可能である。例え
ば、菌体を遠心分離などで除去した後、カチオンおよび
アニオン交換樹脂でイオン性の物質を除き、濃縮すれば
結晶を取得することができる。
The inositol secreted and accumulated in the culture solution can be used as a feed without isolation and collection as it is. In addition, inositol can be collected from a culture solution or a reaction solution by a known method. For example, crystals can be obtained by removing cells by centrifugation or the like, removing ionic substances with a cation and anion exchange resin, and concentrating.

【0015】[0015]

【実施例】以下、実施例により本発明を具体的に説明す
る。 実施例1 (ブロモピルビン酸耐性変異株の分離)キャンディダ・
ボイディニイδ−65株の菌体を常法によりN−メチル
−N’−ニトロ−N−ニトロソグアニジン処理(300
μg /ml、30℃10分)した後、この細胞を適当に希
釈し、表1に示した培地に5mg/lの濃度でブロモピル
ビン酸(BP)を加えた平板培地に塗布し、30℃で4
日間培養した。生育してきた変異処理したキャンディダ
・ボイディニイのコロニーを純粋な変異株として単離
し、キャンディダ・ボイディニイBP22(FERM
P−16743)を取得した。
The present invention will be described below in detail with reference to examples. Example 1 (Isolation of a bromopyruvic acid resistant mutant)
Cells of the Voidinii δ-65 strain were treated with N-methyl-N′-nitro-N-nitrosoguanidine (300
(g / ml, 30 ° C. for 10 minutes), the cells were diluted appropriately, applied to a plate medium containing bromopyruvic acid (BP) at a concentration of 5 mg / l in the medium shown in Table 1, and then plated at 30 ° C. At 4
Cultured for days. The grown Candida voidinii colonies that have undergone mutagenesis are isolated as pure mutants, and Candida voidinii BP22 (FERM) is isolated.
P-16743).

【0016】[0016]

【表1】 (ブロモピルビン酸耐性変異株の耐性度)キャンディダ
・ボイディニイBP22及びキャンディダ・ボイディニ
イδ−65の各菌株を表1に示す寒天培地を除いた培地
を用いて30℃で24時間振盪培養し、生育した菌体を
各々集菌し生理食塩水で洗浄した。これらの菌体懸濁液
を表2に示す濃度のブロモピルビン酸を添加した表1に
示す培地5mlに各々植菌して、30℃にて培養し、各
菌株の72時間後の生育度を調べた。その結果は表2に
示すとおりである。本発明で使用するにブロモピルビン
酸耐性な変異株は親株と比較して、高濃度のブロモピル
ビン酸によって生育が阻害されず、強いブロモピルビン
酸耐性を獲得していることを示している。
[Table 1] (Degree of Resistance of Bromopyruvic Acid-Resistant Mutants) Each strain of Candida voidinii BP22 and Candida voidinii δ-65 was shake-cultured at 30 ° C. for 24 hours using a medium excluding the agar medium shown in Table 1, The grown cells were collected and washed with physiological saline. Each of these cell suspensions was inoculated into 5 ml of the medium shown in Table 1 to which bromopyruvic acid at the concentration shown in Table 2 was added, and cultured at 30 ° C. Examined. The results are as shown in Table 2. The mutant strain resistant to bromopyruvate used in the present invention shows that growth was not inhibited by a high concentration of bromopyruvic acid and that the mutant strain acquired strong bromopyruvic acid resistance as compared with the parent strain.

【0017】[0017]

【表2】 実施例2 (発酵法によるブロモピルビン酸耐性変異株の培養およ
びイノシトールの生産)キャンディダ・ボイディニイB
P22及びキャンディダ・ボイディニイδ−65を各々
表3に示した培地5mlに一白金耳植菌し、30℃で、
24時間振とうして前培養した。この培養液を予め11
5℃10分蒸気滅菌した表4に示した組成の培地50ml
を含む500ml容の三角フラスコに植え継ぎ、180rp
m 、振幅30cmの条件下で72時間培養した後、予め滅
菌したグルコースを50g/lになるように添加し、総
計120時間培養した。
[Table 2] Example 2 (Culture of bromopyruvic acid-resistant mutant strain and production of inositol by fermentation method) Candida voidinii B
P22 and Candida voidinii δ-65 were each inoculated in a loop of 5 ml of the medium shown in Table 3 at 30 ° C.
Preculture was performed by shaking for 24 hours. This culture solution was previously
50 ml of a medium having the composition shown in Table 4 and steam sterilized at 5 ° C. for 10 minutes.
And transferred to a 500 ml Erlenmeyer flask containing
After culturing for 72 hours under the conditions of m 2 and amplitude 30 cm, glucose previously sterilized was added at 50 g / l, and culturing was performed for a total of 120 hours.

【0018】培養終了後、菌体、炭酸カルシウムを除去
したろ液中のイノシトール濃度を高速液体クロマトグラ
フィ−で定量したところ、表4に示すような結果を得
た。親株と比較し、変異株ではイノシトールの生産量が
大幅に向上している結果を得た。
After completion of the culture, the concentration of inositol in the filtrate from which the cells and calcium carbonate had been removed was quantified by high performance liquid chromatography, and the results shown in Table 4 were obtained. Compared to the parent strain, the mutant strain showed a significant increase in inositol production.

【0019】[0019]

【表3】 [Table 3]

【0020】[0020]

【表4】 実施例3 実施例2での培養液1L分の上清をカチオン交換樹脂ダ
イヤイオンSK1B(三菱化学製)に通液し、その素通
り画分をあつめ、さらにアニオン交換樹脂ダイヤイオン
PA316(三菱化学製)に通液し、その素通り画分を
あつめ、濃縮晶析し、純度98%以上のイノシトール結
晶14.2gを得た。
[Table 4] Example 3 The supernatant of 1 L of the culture solution obtained in Example 2 was passed through a cation exchange resin DIAION SK1B (manufactured by Mitsubishi Chemical Corporation) to collect a flow-through fraction, and further anion exchange resin DIAION PA316 (manufactured by Mitsubishi Chemical Corporation). ), The flow-through fraction was collected, concentrated and crystallized to obtain 14.2 g of inositol crystals having a purity of 98% or more.

【0021】[0021]

【発明の効果】本発明の酵母を用い、発酵法によりイノ
シトールを培養液中に生産すると既存の方法と比較し、
より経済的なイノシトールの生産が可能となる。
According to the present invention, when inositol is produced in a culture solution by a fermentation method using the yeast of the present invention, compared with the existing method,
More economical production of inositol becomes possible.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C12R 1:72) ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI theme coat ゛ (reference) C12R 1:72)

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】ハロゲン化ピルビン酸に耐性を有し、かつ
イノシトール分秘生産能を有する微生物を用いることを
特徴とするイノシトールの製造方法。
1. A method for producing inositol, comprising using a microorganism which is resistant to halogenated pyruvate and has the ability to produce inositol secretion.
【請求項2】ハロゲン化ピルビン酸に耐性を有し、かつ
イノシトール分秘生産能を有する微生物を培養して、培
養液中にイノシトールを蓄積せしめることを特徴とする
請求項1記載のイノシトールの製造方法。
2. The production of inositol according to claim 1, wherein a microorganism having tolerance to halogenated pyruvate and capable of producing inositol secretion is cultured to accumulate inositol in the culture solution. Method.
【請求項3】ハロゲン化ピルビン酸に耐性を有し、かつ
イノシトール生産能を有する微生物を培養して、培養液
中にイノシトールを蓄積せしめ、前記培養液よりイノシ
トールを採取することを特徴とする請求項2記載のイノ
シトールの製造方法。
3. A method of culturing a microorganism having resistance to halogenated pyruvate and capable of producing inositol, accumulating inositol in the culture solution, and collecting inositol from the culture solution. Item 2. The method for producing inositol according to Item 2.
【請求項4】ハロゲン化ピルビン酸耐性を有し、かつイ
ノシトール分泌生産能を有する微生物を培養して、得ら
れた菌体、もしくはそれらの処理物を用い、イノシトー
ルを生成蓄積せしめる反応を行うことを特徴とする請求
項1記載のイノシトールの製造方法。
4. A method of culturing a microorganism having pyruvate halide resistance and capable of producing inositol secretion, and performing a reaction for producing and accumulating inositol using the obtained cells or a processed product thereof. The method for producing inositol according to claim 1, wherein
【請求項5】ハロゲン化ピルビン酸耐性を有し、かつイ
ノシトール分泌生産能を有する微生物を培養して、得ら
れた菌体、もしくはそれらの処理物を用い、イノシトー
ルを生成蓄積せしめる反応を行い、前記反応液よりイノ
シトールを採取することを特徴とする請求項4記載のイ
ノシトールの製造方法。
5. A method of culturing a microorganism which is resistant to halogenated pyruvate and has an ability to produce and secrete inositol, and performing a reaction for producing and accumulating inositol using the obtained cells or a processed product thereof. The method for producing inositol according to claim 4, wherein inositol is collected from the reaction solution.
【請求項6】イノシトール分泌生産能を有する微生物が
キャンディダ属に属する微生物であることを特徴とする
請求項1から5のいずれか1項に記載のイノシトールの
製造方法。
6. The method for producing inositol according to any one of claims 1 to 5, wherein the microorganism capable of producing and secreting inositol is a microorganism belonging to the genus Candida.
【請求項7】キャンディダ属に属する微生物が、キャン
ディダ・ボイディニイであることを特徴とする請求項6
記載のイノシトールの製造方法。
7. The microorganism belonging to the genus Candida is Candida voidinii.
The method for producing inositol according to the above.
JP13341899A 1998-05-25 1999-05-14 Production of inositol Pending JP2000041689A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13341899A JP2000041689A (en) 1998-05-25 1999-05-14 Production of inositol

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP14330698 1998-05-25
JP10-143306 1998-05-25
JP13341899A JP2000041689A (en) 1998-05-25 1999-05-14 Production of inositol

Publications (1)

Publication Number Publication Date
JP2000041689A true JP2000041689A (en) 2000-02-15

Family

ID=26467788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13341899A Pending JP2000041689A (en) 1998-05-25 1999-05-14 Production of inositol

Country Status (1)

Country Link
JP (1) JP2000041689A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049736A1 (en) * 2005-10-28 2007-05-03 Kyowa Hakko Kogyo Co., Ltd. Concentration crystallizer and method
WO2013073483A1 (en) 2011-11-14 2013-05-23 旭化成ケミカルズ株式会社 Method for producing myo-inositol and myo-inositol derivative
WO2013115012A1 (en) 2012-02-02 2013-08-08 旭化成ケミカルズ株式会社 Method for producing scyllo-inositol
WO2018004307A1 (en) 2016-06-30 2018-01-04 씨제이제일제당 (주) Method for enzymatically preparing highly concentrated myo-inositol

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049736A1 (en) * 2005-10-28 2007-05-03 Kyowa Hakko Kogyo Co., Ltd. Concentration crystallizer and method
JP5319923B2 (en) * 2005-10-28 2013-10-16 協和発酵バイオ株式会社 Concentrated crystallization apparatus and method
WO2013073483A1 (en) 2011-11-14 2013-05-23 旭化成ケミカルズ株式会社 Method for producing myo-inositol and myo-inositol derivative
KR20140048334A (en) 2011-11-14 2014-04-23 아사히 가세이 케미칼즈 가부시키가이샤 Method for producing myo-inositol and myo-inositol derivative
EP2921558A1 (en) 2011-11-14 2015-09-23 Asahi Kasei Chemicals Corporation Method for producing myo-inositol and myo-inositol derivative
US9365603B2 (en) 2011-11-14 2016-06-14 Asahi Kasei Chemicals Corporation Method for producing myo-inositol and myo-inositol derivative
US9994871B2 (en) 2011-11-14 2018-06-12 Asahi Kasei Chemicals Corporation Method for producing myo-inositol and myo-inositol derivative
WO2013115012A1 (en) 2012-02-02 2013-08-08 旭化成ケミカルズ株式会社 Method for producing scyllo-inositol
US9505795B2 (en) 2012-02-02 2016-11-29 Asahi Kasei Chemicals Corporation Method for producing scyllo-inositol
WO2018004307A1 (en) 2016-06-30 2018-01-04 씨제이제일제당 (주) Method for enzymatically preparing highly concentrated myo-inositol

Similar Documents

Publication Publication Date Title
JPH0217159B2 (en)
EP0137226B1 (en) Process for the preparation of riboflavin
EP0798377A2 (en) Process for producing aspartase and l-aspartic acid
JPH05292945A (en) New bacillus-subtilis
JP2979767B2 (en) Production of riboflavin by fermentation
JP2000041689A (en) Production of inositol
JPH0838188A (en) Production of inositol and method for taking glucose metabolism antagonistic substance-resistant strain
EP0389620B1 (en) Process for preparing pyruvic acid by fermentation
JPH1042883A (en) Production of inositol and collection of strain resistant to 6-halogeno-6-deoxyglucose
JPH1042860A (en) Production of inositol and acquirement of hexachlorocyclohexane-resistant strain
JPH09154589A (en) Production of erythritol
EP0076516B1 (en) Method for fermentative production of l-proline
JP2002281993A (en) Method for producing shikimic acid
JPH0889262A (en) Production of inositol and preparation of antibiotic resistant strain
JPH1042882A (en) Production of inositol and collection of strain having resistant to cetyltrimethylammonium salt
JPH08258A (en) Microorganism belonging to genus candida and production of inositol with the same
EP0338596B1 (en) Process for the preparation of riboflavin
JPS6228678B2 (en)
EP0337502B1 (en) Process for the preparation of riboflavin
JPH09117295A (en) Production of inositol and production of strain resistant to tertiary amine
JPS63258586A (en) Production of pyruvic acid by fermentation
JP2000078967A (en) Microorganism belonging to citrobacter and production of shikimic acid
JP2000300249A (en) Microorganism secreting shikimic acid to outside of microbial cell and production of shikimic acid
JP4560164B2 (en) Microbial production of glycine
JPH0424037B2 (en)